ZBD(SH:603567) Zheng Quan Zhi Xing·2025-08-29 16:39Group 1 - The law firm Beijing Lantai Law Firm has been commissioned by Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd. to provide legal opinions regarding the company's second extraordinary general meeting of shareholders in 2025 [3][4] - The meeting is scheduled for August 28, 2025, and the law firm will witness the proceedings and provide legal opinions on the relevant matters [5][7] - The law firm confirms that the notice for the meeting was issued in accordance with legal and regulatory requirements, and the actual time, location, and content of the meeting align with the notice [8][9] Group 2 - The meeting was convened by the company's board of directors, and the qualifications of the convenor and attendees were verified to comply with relevant laws and regulations [8][9] - A total of 221 shareholders participated in the meeting, representing 507,558,836 shares with voting rights, which accounts for 53.9384% of the total shares with voting rights [9] - The voting process was conducted in accordance with legal requirements, and the results of the voting were confirmed by the law firm [10] Group 3 - The law firm concluded that the procedures for convening and holding the meeting, as well as the qualifications of the convenor and attendees, were legally valid [10] - The voting procedures and results were also deemed to be legally effective, ensuring compliance with the Company Law and other relevant regulations [10]